Experiment: 2MJL

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.9 mM [U-100% 15N] VcPth, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide, 1 mM DTT	93% H2O/7% D2O	50	6.5	ambient	298
2	3D HNCO	0.9 mM [U-100% 13C; U-100% 15N] VcPth, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide, 1 mM DTT	93% H2O/7% D2O	50	6.5	ambient	298
3	3D HNCA	0.9 mM [U-100% 13C; U-100% 15N] VcPth, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide, 1 mM DTT	93% H2O/7% D2O	50	6.5	ambient	298
4	3D CBCA(CO)NH	0.9 mM [U-100% 13C; U-100% 15N] VcPth, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide, 1 mM DTT	93% H2O/7% D2O	50	6.5	ambient	298
5	3D HNCACB	0.9 mM [U-100% 13C; U-100% 15N] VcPth, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide, 1 mM DTT	93% H2O/7% D2O	50	6.5	ambient	298
6	3D H(CCO)NH	0.9 mM [U-100% 13C; U-100% 15N] VcPth, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide, 1 mM DTT	93% H2O/7% D2O	50	6.5	ambient	298
7	3D C(CO)NH	0.9 mM [U-100% 13C; U-100% 15N] VcPth, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide, 1 mM DTT	93% H2O/7% D2O	50	6.5	ambient	298
8	3D HCCH-TOCSY	0.9 mM [U-100% 13C; U-100% 15N] VcPth, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide, 1 mM DTT	100% D2O	50	6.5	ambient	298
9	2D 1H-13C HSQC	0.9 mM [U-100% 13C; U-100% 15N] VcPth, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide, 1 mM DTT	100% D2O	50	6.5	ambient	298
10	2D 1H-13C HSQC aromatic	0.9 mM [U-100% 13C; U-100% 15N] VcPth, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide, 1 mM DTT	100% D2O	50	6.5	ambient	298
11	3D 1H-15N NOESY	0.9 mM [U-100% 15N] VcPth, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide, 1 mM DTT	93% H2O/7% D2O	50	6.5	ambient	298
12	3D 1H-13C NOESY aliphatic	0.9 mM [U-100% 13C; U-100% 15N] VcPth, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide, 1 mM DTT	100% D2O	50	6.5	ambient	298
13	3D 1H-13C NOESY aromatic	0.9 mM [U-100% 13C; U-100% 15N] VcPth, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide, 1 mM DTT	100% D2O	50	6.5	ambient	298
14	3D-HN(CA)CO	0.9 mM [U-100% 13C; U-100% 15N] VcPth, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide, 1 mM DTT	93% H2O/7% D2O	50	6.5	ambient	298
15	2D-CBHE	0.9 mM [U-100% 13C; U-100% 15N] VcPth, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide, 1 mM DTT	100% D2O	50	6.5	ambient	298
16	2D-CBHD	0.9 mM [U-100% 13C; U-100% 15N] VcPth, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide, 1 mM DTT	100% D2O	50	6.5	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	INOVA	600
2	Bruker	AVANCE	800

NMR Refinement
Method	Details	Software
molecular dynamics		CYANA

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	200
Conformers Submitted Total Number	10
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure solution	CYANA		Guntert, Mumenthaler and Wuthrich
2	refinement	CNS		Brunger, Adams, Clore, Gros, Nilges and Read
3	validation	PSVS		Bhattacharya and Montelione
4	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.